Biologics in refractory myositis: experience in juvenile vs. adult myositis; part II: emerging biologic and other therapies on the horizon

DOI: 10.1186/s12969-019-0361-2

Keywords: Idiopathic inflammatory myopathies, Dermatomyositis, Polymyositis, Juvenile dermatomyositis, Interferon, Cytokines

Full-Text